Fungizone Intravenous Injection 50 mg Injection
PDF Leaflet Revision Date: 12 April 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of progressive, potentially life-threatening fungal infections.
Dosage (summary)
Initial dose: 0.25 mg/kg/day, may increase to 0.5-1.5 mg/kg based on tolerance.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; avoid breastfeeding.
Key Drug Interactions
- Nephrotoxic medications
- Corticosteroids
- Flucytosine
- Imidazoles
Contraindications
- Hypersensitivity to amphotericin B or components
Common side effects
- Nausea
- Vomiting
- Chills
- Hypokalaemia
- Hypotension
Counselling Points
- Administer under close supervision
- Monitor for intolerance
- Avoid rapid infusion
Serious warnings
- Potentially fatal cardiac arrest with overdose
- Monitor renal function
Important Disclaimer
The Fungizone Intravenous Injection 50 mg Injection professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
